Vaccinia Virus Infection in Monkeys, Brazilian Amazon

Abrahão, Jônatas S.; Silva-Fernandes, André T.; Lima, Larissa S.; Campos, Rafael K.; Guedes, Maria I. M. C.; Cota, Marcela M. G.; Assis, Felipe L.; Borges, Iara A.; Souza-Júnior, Milton F.; Lobato, Zélia I. P.; Bonjardim, Cláudio A.; Ferreira, Paulo C. P.; Trindade, Giliane S.; Kroon, Erna G.
June 2010
Emerging Infectious Diseases;Jun2010, Vol. 16 Issue 6, p976
Academic Journal
To detect orthopoxvirus in the Brazilian Amazon, we conducted a serosurvey of 344 wild animals. Neutralizing antibodies against orthopoxvirus were detected by plaque-reduction neutralizing tests in 84 serum samples. Amplicons from 6 monkey samples were sequenced. These amplicons identified vaccinia virus genetically similar to strains from bovine vaccinia outbreaks in Brazil.


Related Articles

  • A Phylogeographic Investigation of African Monkeypox. Yoshinori Nakazawa; Mauldin, Matthew R.; Emerson, Ginny L.; Reynolds, Mary G.; Ryan Lash, R.; Jinxin Gao; Hui Zhao; Yu Li; Muyembe, Jean-Jacques; Kingebeni, Placide Mbala; Okito Wemakoy; Malekani, Jean; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S. // Viruses (1999-4915);2015, Vol. 7 Issue 4, p2168 

    Monkeypox is a zoonotic disease caused by a virus member of the genus Orthopoxvirus and is endemic to Central and Western African countries. Previous work has identified two geographically disjuct clades of monkeypox virus based on the analysis of a few genomes coupled with epidemiological and...

  • Antibody Inhibition of a Viral Type 1 Interferon Decoy Receptor Cures a Viral Disease by Restoring Interferon Signaling in the Liver. Ren-Huan Xu; Rubio, Daniel; Roscoe, Felicia; Krouse, Tracy E.; Truckenmiller, Mary Ellen; Norbury, Christopher C.; Hudson, Paul N.; Damon, Inger K.; Alcamí, Antonio; Sigal, Luis J. // PLoS Pathogens;Jan2012, Vol. 8 Issue 1, Special section p1 

    Type 1 interferons (T1-IFNs) play a major role in antiviral defense, but when or how they protect during infections that spread through the lympho-hematogenous route is not known. Orthopoxviruses, including those that produce smallpox and mousepox, spread lympho-hematogenously. They also encode...

  • Cowpox virus transmission from rats to monkeys, the Netherlands. Martina, Byron E. E.; Van Doornum, Gerard; Dorrestein, Gerry M.; Niesters, Hubert G. M.; Stittelaar, Koert J.; Wolters, Marno A. B. I.; Van Bolhuis, Hester G. H.; Osterhaus, Albert D. M. E. // Emerging Infectious Diseases;Jun2006, Vol. 12 Issue 6, p1005 

    We report an outbreak of cowpox virus among monkeys at a sanctuary for exotic animals. Serologic analysis and polymerase chain reaction were performed on blood and swab samples from different rodent species trapped at the sanctuary during the outbreak. Sequence comparison and serologic results...

  • Retrospective Analysis of Monkeypox Infection. Dubois, Melissa E.; Slifka, Mark K. // Emerging Infectious Diseases;Apr2008, Vol. 14 Issue 4, p592 

    Serologic cross-reactivity between orthopoxviruses is a substantial barrier to laboratory diagnosis of specific orthopoxvirus infections and epidemiologic characterization of disease outbreaks. Historically, time-consuming and labor-intensive strategies such as cross-adsorbed neutralization...

  • Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity. Jae-Min Song; Bao-Zhong Wang; Kyoung-Mi Park; Van Rooijen, Nico; Fu-Shi Quan; Min-Chul Kim; Hyun-Tak Jin; Pekosz, Andrew; Compans, Richard W.; Sang-Moo Kang // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: Current influenza vaccines based on the hemagglutinin protein are strain specific and do not provide good protection against drifted viruses or emergence of new pandemic strains. An influenza vaccine that can confer cross-protection against antigenically different influenza A strains...

  • HIV?1 neutralizing antibodies: How full is the bottle? Moore, John P.; Burton, Dennis R. // Nature Medicine;Feb1999, Vol. 5 Issue 2, p142 

    Potent neutralizing antibodies protect monkeys from SHIV challenge, but will vaccines ever be able to elicit antibody responses this powerful? (pages 204?216)

  • A simple restriction fragment PCR approach for discrimination of humanpathogenic Old World animal Orthopoxvirus species. Huemer, Hartwig P.; Hönlinger, Bettina; Höpfl, Reinhard // Canadian Journal of Microbiology;Feb2008, Vol. 54 Issue 2, p159 

    There are reliable polymerase chain reaction assays available for exclusion of Variola virus from other poxviruses. However, the discrimination of humanpathogenic animal Orthopoxviridae is more challenging because of the high genomic conservation. Based on the variability of the A36R gene, we...

  • Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans. Rice, Amanda D.; Adams, Mathew M.; Lampert, Bernhard; Foster, Scott; Lanier, Randall; Robertson, Alice; Painter, George; Moyer, Richard W. // Viruses (1999-4915);Feb2011, Vol. 3 Issue 2, p63 

    CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. CMX001 has dramatically increased potency versus CDV against all dsDNA viruses and, in contrast to CDV, is orally available and has...

  • Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunity. Luzheng Liu; Qiong Zhong; Tian Tian; Dubin, Krista; Athale, Shruti K.; Kupper, Thomas S. // Nature Medicine;Feb2010, Vol. 16 Issue 2, p224 

    Variola major (smallpox) infection claimed hundreds of millions lives before it was eradicated by a simple vaccination strategy: epicutaneous application of the related orthopoxvirus vaccinia virus (VACV) to superficially injured skin (skin scarification, s.s.). However, the remarkable success...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics